Back to Journals » Clinical Ophthalmology » Volume 7

Primary probing for congenital nasolacrimal duct obstruction with manually curved Bowman probes

Authors Serin D, Buttanri IB, Sevim MS, Buttanri B

Received 4 November 2012

Accepted for publication 3 December 2012

Published 11 January 2013 Volume 2013:7 Pages 109—112

DOI https://doi.org/10.2147/OPTH.S39926

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Didem Serin,1 Ibrahim Bulent Buttanri,1 Mehmet Sahin Sevim,1 Bahtinur Buttanri2

1
Eye Clinic, Haydarpasa Numune Education and Research Hospital, 2Eye Clinic, Sisli Etfal Education and Research Hospital, Istanbul, Turkey

Purpose: To evaluate the effect of the shape of Bowman probes on the success of primary probing for congenital nasolacrimal duct obstruction.
Materials and methods: Records of 42 nasolacrimal duct obstructions in 37 children who underwent probing with straight Bowman probes (group A) and 128 nasolacrimal duct obstructions in 110 children who underwent probing with Bowman probes manually bent to mimic the natural curve of the bony nasolacrimal pathway (group B) were evaluated and compared. All children were under 2 years of age. The main outcome was successful probing. Successful probing was defined as a complete resolution of signs and symptoms.
Results: The mean age of the patients was 16.4 ± 4.1 months (range 8–24 months) in group A and 16.8 ± 4.2 months (range 7–24 months) in group B. No canalicular or nasolacrimal sac pathologies were diagnosed during probing. The success rate was 76.2% (32/42) in group A and 91.4% (117/128) in group B. The difference was statistically significant (P < 0.01).
Conclusion: Manually curved probes can be used efficiently during probing and increase the success rates.

Keywords: nasolacrimal duct obstruction, success rate, curved Bowman probe, <2-year-old children

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Management of orbital fractures: challenges and solutions

Boyette JR, Pemberton JD, Bonilla-Velez J

Clinical Ophthalmology 2015, 9:2127-2137

Published Date: 17 November 2015

Aloe vera gel facilitates re-epithelialization of corneal alkali burn in normal and diabetic rats

Atiba A, Wasfy T, Abdo W, Ghoneim A, Kamal T, Shukry M

Clinical Ophthalmology 2015, 9:2019-2026

Published Date: 28 October 2015

Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier

Wang X, Liu P, Yang W, Li L, Li P, Liu Z, Zhuo Z, Gao Y

International Journal of Nanomedicine 2014, 9:4899-4909

Published Date: 23 October 2014

The long-term survival of a thymic carcinoma patient treated with S-1: a case report and literature review

Tanaka H, Morimoto T, Taima K, Tanaka Y, Nakamura K, Hayashi A, Kurose A, Okumura K, Takanashi S

OncoTargets and Therapy 2014, 7:87-90

Published Date: 27 December 2013

Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body

Jacobs DJ, Grube TJ, Flynn Jr HW, Greven CM, Pathengay A, Miller D, Sanke RF, Thorman J

Clinical Ophthalmology 2013, 7:1727-1730

Published Date: 27 August 2013

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension

Lanzl I, Hamacher T, Rosbach K, Ramez MO, Rothe R, Růžičková E, Karhanová M, Kimmich F

Clinical Ophthalmology 2013, 7:901-910

Published Date: 16 May 2013

Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease

Feucht N, Schönbach EM, Lanzl I, Kotliar K, Lohmann CP, Maier M

Clinical Ophthalmology 2013, 7:173-178

Published Date: 18 January 2013